TGFβ1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies

Cancer Genetics and Cytogenetics

Volumn 196, Issue 1, 2010, Pages 68-75

  Wei, Bing Bing ^a   Xi, Bo ^b,c   Wang, Ruoqi ^d   Bai, Jin Ming ^a   Chang, Jun Kai ^a   Zhang, Yun Yun ^a   Yoneda, Raegan ^e   Su, Jian Tang ^a   Hua, Li Xin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^c CAPITAL INSTITUTE OF PEDIATRICS   (China)

^d YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

^e HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; THYMINE; TRANSFORMING GROWTH FACTOR BETA1;

AGE DISTRIBUTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; ETHNICITY; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN POLYMORPHISM; SEX DIFFERENCE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; NEOPLASM;

CASE-CONTROL STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NEOPLASMS; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 70949107039     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.09.016     Document Type: Article

References (49)

1. Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor beta in human disease. N Engl J Med 342 (2000) 1350-1358
2. Boesen C.C., Radaev S., Motyka S.A., Patamawenu A., and Sun P.D. The 1.1 A crystal structure of human TGF-beta type II receptor ligand binding domain. Structure 10 (2002) 913-919
3. Grainger D.J., Heathcote K., Chiano M., Snieder H., Kemp P.R., Metcalfe J.C., Carter N.D., and Spector T.D. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8 (1999) 93-97
4. Ravitz M.J., and Wenner C.E. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta. Adv Cancer Res 71 (1997) 165-207
5. Wikstrom P., Damber J., and Bergh A. Role of transforming growth factor-beta1 in prostate cancer. Microsc Res Tech 52 (2001) 411-419
6. Barrack E.R. TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 31 (1997) 61-70
7. Fujii D., Brissenden J.E., Derynck R., and Francke U. Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet 12 (1986) 281-288
8. Yokota M., Ichihara S., Lin T.L., Nakashima N., and Yamada Y. Association of a T29 → C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101 (2000) 2783-2787
9. Cox D.G., Penney K., Guo Q., Hankinson S.E., and Hunter D.J. TGF-B1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study. BMC Cancer 7 (2007) 175
10. Dunning A.M., Ellis P.D., McBride S., Kirschenlohr H.L., Healey C.S., Kemp P.R., Luben R.N., Chang-Claude J., Mannermaa A., Kataja V., Pharoah P.D., Easton D.F., Ponder B.A., and Metcalfe J.C. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 63 (2003) 2610-2615
11. Feigelson H.S., Patel A.V., Diver W.R., Stevens V.L., Thun M.J., and Calle E.E. Transforming growth factor beta receptor type I and transforming growth factor beta1 polymorphisms are not associated with postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 15 (2006) 1236-1237
12. Jin Q., Hemminki K., Grzybowska E., Klaes R., Soderberg M., Zientek H., Rogozinska-Szczepka J., Utracka-Hutka B., Pamula J., Pekala W., and Forsti A. Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers. Int J Cancer 112 (2004) 94-99
13. Krippl P., Langsenlehner U., Renner W., Yazdani-Biuki B., Wolf G., Wascher T.C., Paulweber B., Bahadori B., and Samonigg H. The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk. Cancer Lett 201 (2003) 181-184
14. Le Marchand L., Haiman C.A., van den Berg D., Wilkens L.R., Kolonel L.N., and Henderson B.E. T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev 13 (2004) 412-415
15. Lee K.M., Park S.K., Hamajima N., Tajima K., Yoo K.Y., Shin A., Noh D.Y., Ahn S.H., Hirvonen A., and Kang D. Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk. Breast Cancer Res Treat 90 (2005) 149-155
16. Quarmby S., Fakhoury H., Levine E., Barber J., Wylie J., Hajeer A.H., West C., Stewart A., Magee B., and Kumar S. Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int J Radiat Biol 79 (2003) 137-143
17. Shin A., Shu X.O., Cai Q., Gao Y.T., and Zheng W. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages. Cancer Epidemiol Biomarkers Prev 14 (2005) 1567-1570
18. Crivello A., Giacalone A., Vaglica M., Scola L., Forte G.I., Macaluso M.C., Raimondi C., Di Noto L., Bongiovanni A., Accardo A., Candore G., Palmeri L., Verna R., Caruso C., Lio D., and Palmeri S. Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma. Ann NY Acad Sci 1089 (2006) 98-103
19. Saltzman B.S., Yamamoto J.F., Decker R., Yokochi L., Theriault A.G., Vogt T.M., and Le Marchand L. Association of genetic variation in the transforming growth factor β-1 gene with serum levels and risk of colorectal neoplasia. Cancer Res 68 (2008) 1236-1244
20. Zhang Y., Liu B., Jin M., Ni Q., Liang X., Ma X., Yao K., Li Q., and Chen K. Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: a population-based case-control study in China. Cancer Lett 275 (2009) 102-108
21. Garcia-Gonzalez M.A., Strunk M., Piazuelo E., Benito R., Santolaria S., Jimenez P., Sopena F., Pascual C., Simon M.A., Sainz R., and Lanas A. TGF-B1 gene polymorphisms: their relevance in the susceptibility to Helicobacter pylori-related diseases. Genes Immun 7 (2006) 640-646
22. Garcia-Gonzalez M.A., Lanas A., Quintero E., Nicolas D., Parra-Blanco A., Strunk M., Benito R., Angel Simon M., Santolaria S., Sopena F., Piazuelo E., Jimenez P., Pascual C., Mas E., Irun P., Espinel J., Campo R., Manzano M., Geijo F., Pellise M., Gonzalez-Huix F., Nieto M., Espinos J., Tito L., Bujanda L., and Zaballa M. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol 102 (2007) 1878-1892
23. Jin G., Wang L., Chen W., Hu Z., Zhou Y., Tan Y., Wang J., Hua Z., Ding W., Shen J., Zhang Z., Wang X., Xu Y., and Shen H. Variant alleles of TGF-B1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. Int J Cancer 120 (2007) 1330-1335
24. Li T., Cao B.W., Dai Y., Cui H., Yang H.L., and Xu C.Q. Correlation of transforming growth factor beta-1 gene polymorphisms C-509T and T869C and the risk of gastric cancer in China. J Gastroenterol Hepatol 23 (2008) 638-642
25. Zhang P., Di J.Z., Zhu Z.Z., Wu H.M., Wang Y., Zhu G., Zheng Q., and Hou L. Association of transforming growth factor-beta 1 polymorphisms with genetic susceptibility to TNM stage I or II gastric cancer. Jpn J Clin Oncol 38 (2008) 861-866
26. Falleti E., Fabris C., Toniutto P., Fontanini E., Cussigh A., Bitetto D., Fornasiere E., Avellini C., Minisini R., and Pirisi M. TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer. Cytokine 44 (2008) 256-261
27. Kim Y.J., Lee H.S., Im J.P., Min B.H., Kim H.D., Jeong J.B., Yoon J.H., Kim C.Y., Kim M.S., Kim J.Y., Jung J.H., Kim L.H., Park B.L., and Shin H.D. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 35 (2003) 196-202
28. Migita K., Miyazoe S., Maeda Y., Daikoku M., Abiru S., Ueki T., Yano K., Nagaoka S., Matsumoto T., Nakao K., Hamasaki K., Yatsuhashi H., Ishibashi H., and Eguchi K. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol 42 (2005) 505-510
29. Colakogullari M., Ulukaya E., Yilmaztepe Oral A., Aymak F., Basturk B., Ursavas A., and Oral H.B. The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients. Cell Biochem Funct 26 (2008) 283-290
30. Kang H.G., Chae M.H., Park J.M., Kim E.J., Park J.H., Kam S., Cha S.I., Kim C.H., Park R.W., Park S.H., Kim Y.L., Kim I.S., Jung T.H., and Park J.Y. Polymorphisms in TGF-beta1 gene and the risk of lung cancer. Lung Cancer 52 (2006) 1-7
31. Park K.H., Lo Han S.G., Whang Y.M., Lee H.J., Yoo Y.D., Lee J.W., Shin S.W., and Kim Y.H. Single nucleotide polymorphisms of the TGF-β1 gene and lung cancer risk in a Korean population. Cancer Genet Cytogenet 169 (2006) 39-44
32. Ewart-Toland A., Chan J.M., Yuan J., Balmain A., and Ma J. A gain of function TGF-B1 polymorphism may be associated with late stage prostate cancer. Cancer Epidemiol Biomarkers Prev 13 (2004) 759-764
33. Faria P.C., Saba K., Neves A.F., Cordeiro E.R., Marangoni K., Freitas D.G., and Goulart L.R. Transforming growth factor-beta 1 gene polymorphisms and expression in the blood of prostate cancer patients. Cancer Invest 25 (2007) 726-732
34. Kang D., Lee K.M., Park S.K., Berndt S.I., Peters U., Reding D., Chatterjee N., Welch R., Chanock S., Huang W.Y., and Hayes R.B. Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev 16 (2007) 1581-1586
35. Li Z., Habuchi T., Tsuchiya N., Mitsumori K., Wang L., Ohyama C., Sato K., Kamoto T., Ogawa O., and Kato T. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10. Carcinogenesis 25 (2004) 237-240
36. Meyer A., Dork T., Bogdanova N., Brinkhaus M.J., Wiese B., Hagemann J., Serth J., Bremer M., Baumann R., Karstens J.H., and Machtens S. TGF-β1 gene polymorphism Leu10Pro (c.29T → C), prostate cancer incidence and quality of life in patients treated with brachytherapy. World J Urol (2008) doi:10.1007/s00345-008-0354-0
37. Mazur G., Bogunia-Kubik K., Wrobel T., Kuliczkowski K., and Lange A. TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients. Cytokine 33 (2006) 145-149
38. Stanczuk G.A., Tswana S.A., Bergstrom S., and Sibanda E.N. Polymorphism in codons 10 and 25 of the transforming growth factor-beta 1 (TGF-beta1) gene in patients with invasive squamous cell carcinoma of the uterine cervix. Eur J Immunogenet 29 (2002) 417-421
39. Wei Y.S., Xu Q.Q., Wang C.F., Pan Y., Liang F., and Long X.K. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma. Tissue Antigens 70 (2007) 464-469
40. Wei Y.S., Zhu Y.H., Du B., Yang Z.H., Liang W.B., Lv M.L., Kuang X.H., Tai S.H., Zhao Y., and Zhang L. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Clin Chim Acta 380 (2007) 165-169
41. Lau J., Ioannidis J.P., and Schmid C.H. Quantitative synthesis in systematic reviews. Ann Intern Med 127 (1997) 820-826
42. Berman N.G., and Parker R.A. Meta-analysis: neither quick nor easy. BMC Med Res Methodol 2 (2002) 10
43. Mantel N., and Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22 (1959) 719-748
44. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
45. Galbraith R.F. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 7 (1988) 889-894
46. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
47. Danielpour D. Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate. Eur J Cancer 41 (2005) 846-857
48. Hishida A., Iwata H., Hamajima N., Matsuo K., Mizutani M., Iwase T., Miura S., Emi N., Hirose K., and Tajima K. Transforming growth factor β1 T29C polymorphism and breast cancer risk in Japanese women. Breast Cancer 10 (2003) 63-69
49. Nei M., and Roychoudhury A.K. Genetic variation within and between the three major races of man, Caucasoids, Negroids, and Mongoloids. Am J Hum Genet 26 (1974) 421-443